Form 4 Tracker
Ronald C Renaud JR

Director; Director, CEO & President · 3 filings · Latest: Jun 9, 2026

Kailera Therapeutics, Inc.
Upstream Bio, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
KLRA
Ronald C Renaud JRDirector, CEO & PresidentJun 9, 2026
Option Exercise
$5.2538,094$200.0K38,094